Gene · 2923
Papers3,219
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,219
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A positive feedback between PDIA3P1 and OCT4 promotes the cancer stem cell properties of esophageal squamous cell carcinoma. | Cell Commun Signal | 2024 | 38254118 | PubTator, text mining | PubMed |
| Exploring the mechanism of Celastrol in the treatment of rheumatoid arthritis based on systems pharmacology and multi-omics. | Sci Rep | 2024 | 38238321 | PubTator, text mining | PubMed |
| Rescue of NLRC5 expression restores antigen processing machinery in head and neck cancer cells lacking functional STAT1 and p53. | Cancer Immunol Immunother | 2024 | 38231444 | PubTator, text mining | PubMed |
| Strategies to overcome low MHC-I expression in paediatric and adult tumours. | Immunother Adv | 2024 | 38223409 | PubTator, text mining | PubMed |
| Conditional hepatocyte ablation of PDIA1 uncovers indispensable roles in both APOB and MTTP folding to support VLDL secretion. | Mol Metab | 2024 | 38211723 | PubTator, text mining | PubMed |
| Targeting Senescent Cells as Therapy for CKD. | Kidney360 | 2024 | 38049936 | PubTator, text mining | PubMed |
| Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells. | Mol Metab | 2024 | 38030123 | PubTator, text mining | PubMed |
| Identification and characterization of calreticulin as a novel plasminogen receptor. | J Biol Chem | 2024 | 37979915 | PubTator, text mining | PubMed |
| Chemical Hypoxic Preconditioning Improves Survival and Proliferation of Mesenchymal Stem Cells. | Appl Biochem Biotechnol | 2024 | 37755639 | PubTator, text mining | PubMed |
| Does vitamin D protect or treat Parkinson's disease? A narrative review. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 37555855 | PubTator, text mining | PubMed |
| WITHDRAWN: Progranulin inhibits phospholipase sPLA2-IIA to control neuroinflammation. | bioRxiv | 2024 | 37066328 | PubTator, text mining | PubMed |
| Simultaneous proteome localization and turnover analysis reveals spatiotemporal features of protein homeostasis disruptions. | bioRxiv | 2024 | 36711879 | PubTator, text mining | PubMed |
| The role of PDIA3 in oral squamous cell carcinoma and its value as A diagnostic and prognostic biomarker. | Heliyon | 2023 | 38213579 | PubTator, text mining | PubMed |
| Comparative Analysis of Differential Cellular Transcriptome and Proteome Regulation by HIV-1 and HIV-2 Pseudovirions in the Early Phase of Infection. | Int J Mol Sci | 2023 | 38203551 | PubTator, text mining | PubMed |
| VDR and PDIA3 Are Essential for Activation of Calcium Signaling and Membrane Response to 1,25(OH)2D3 in Squamous Cell Carcinoma Cells. | Cells | 2023 | 38201216 | PubTator, text mining | PubMed |
| Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival. | Front Immunol | 2023 | 38179040 | PubTator, text mining | PubMed |
| Sex hormone-binding globulin improves lipid metabolism and reduces inflammation in subcutaneous adipose tissue of metabolic syndrome-affected horses. | Front Mol Biosci | 2023 | 38146533 | PubTator, text mining | PubMed |
| PDIA4 Is a Host Factor Important for Lymphocytic Choriomeningitis Virus Infection. | Viruses | 2023 | 38140584 | PubTator, text mining | PubMed |
| The PPP1R15 Family of eIF2-alpha Phosphatase Targeting Subunits (GADD34 and CReP). | Int J Mol Sci | 2023 | 38139150 | PubTator, text mining | PubMed |
| SOX2-OT Binds with ILF3 to Promote Head and Neck Cancer Progression by Modulating Crosstalk between STAT3 and TGF-β Signaling. | Cancers (Basel) | 2023 | 38136312 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2923/papers?page=8